Lensar (LNSR) Profit After Tax (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,591.91% |
| Dec 31, 2025 | 60.73% |
| Sep 30, 2025 | -110.49% |
| Jun 30, 2025 | 93.55% |
| Mar 31, 2025 | -46.21% |
| Dec 31, 2024 | -1,145.14% |
| Sep 30, 2024 | 83.39% |
| Jun 30, 2024 | -319.24% |
| Mar 31, 2024 | 45.06% |
| Dec 31, 2023 | -252.88% |
| Sep 30, 2023 | 129.34% |
| Jun 30, 2023 | -104.89% |
| Mar 31, 2023 | -71.57% |
| Dec 31, 2022 | 37.61% |
| Sep 30, 2022 | 40.95% |
| Jun 30, 2022 | -1.27% |
| Mar 31, 2022 | -71.04% |
| Dec 31, 2021 | 36.60% |
| Sep 30, 2021 | -41.10% |
| Jun 30, 2021 | 15.82% |
| Mar 31, 2021 | 24.11% |
| Dec 31, 2020 | -43.36% |
| Sep 30, 2020 | -5.92% |
| Jun 30, 2020 | -22.00% |
| Mar 31, 2020 | -49.35% |
| Dec 31, 2019 | 57.58% |